MU

Melissa Ullerich

Chief Corporate Communications & Investor Relations Officer at SAB Biotherapeutics

About

Links

Timeline

  • Chief Corporate Communications & Investor Relations Officer

    March, 2020 - present

  • Senior Vice President Corporate Communications

    November, 2018